Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs. In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.
4,3,5-DOB · 4-Br-3,5-DMA · 4-Bromo-3,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyamphetamine · DOB
5-Br-2,4-DMA · 5-Bromo-2,4-dimethoxyamphetamine · m-DOB · META-DOB
2C-B-2-EtO · 2CB-2ETO · 4-Bromo-2-ethoxy-5-methoxyphenethylamine
2-Bromo-4,5-dimethoxy-N-methylphenethylamine · N-Me-2-Br-DMPEA
2-Br-4,5-DMA · 2-Bromo-4,5-dimethoxyamphetamine · o-DOB · ORTHO-DOB
4,2,3-DOB · 4-Bromo-2,3-dimethoxyamphetamine
3,2,4-DOB · 3-Bromo-2,4-dimethoxyamphetamine
2,3,4-DOB · 2-Bromo-3,4-dimethoxyamphetamine
3-Bromo-2,5-dimethoxyamphetamine · 3-DOB · iso-DOB
3,4,5-DOB · 3-Bromo-4,5-dimethoxyamphetamine
2,3,6-DOB · 2-Bromo-3,6-dimethoxyamphetamine
2,4,6-DOB · 2-Bromo-4,6-dimethoxyamphetamine
4-Bromo-2,5-dimethoxy-β-methylphenethylamine · BMB
3-Br-2C-D · 3-Bromo-4-methyl-2,5-dimethoxyphenethylamine